Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) hold great potential for safety pharmacology studies. Human iPSC-derived cardiomyocytes can be used for high throughput screening, MEA, patch clamp and disease modeling applications.
Creating a European Centre of Excellence dedicated to Cardiac Safety Evaluation
The 3rd edition of the Biopharma Outsourcing meeting will take place in Toulouse this year. The meeting covers all aspects of service, competence and product sourcing and outsourcing for pharmaceutical and biotech companies.
The PhysioS’Team is pleased to confirm that we’ll attend the upcoming SPS meeting in Berlin.
The company has received international recognition for its expertise in cardiac electrophysiology and preclinical safety studies. To expand its reach and complete its range of services and assays, PhysioStim is expected to team up with another CRO from across the Channel.